These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6175864

  • 1. Refsum's disease and metabolism of phytanic acid.
    Stokke O, Refsum S.
    Lancet; 1982 Apr 17; 1(8277):906-7. PubMed ID: 6175864
    [No Abstract] [Full Text] [Related]

  • 2. Metabolism of phytanic acid in Refsum's disease.
    Billimoria JD, Clemens ME, Gibberd FB, Whitelaw MN.
    Lancet; 1982 Jan 23; 1(8265):194-6. PubMed ID: 6172683
    [No Abstract] [Full Text] [Related]

  • 3. Occurrence of novel branched-chain fatty acids in Refsum's disease.
    Dulaney JT, Williams M, Evans JE, Costello CE, Kolodny EH.
    Biochim Biophys Acta; 1978 Apr 28; 529(1):1-12. PubMed ID: 76480
    [Abstract] [Full Text] [Related]

  • 4. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
    Greter J, Lindstedt S, Steen G.
    Clin Chem; 1983 Mar 28; 29(3):434-7. PubMed ID: 6186413
    [Abstract] [Full Text] [Related]

  • 5. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome?
    Poulos A, Sharp P, Whiting M.
    Clin Genet; 1984 Dec 28; 26(6):579-86. PubMed ID: 6209040
    [Abstract] [Full Text] [Related]

  • 6. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL, Jonniaux G, Voet W, Van Den Bergen CJ.
    Biomedicine; 1974 Nov 28; 20(6):398-407. PubMed ID: 4141904
    [No Abstract] [Full Text] [Related]

  • 7. Disorders related to the metabolism of phytanic acid.
    Stokke O, Skjeldal OH, Høie K.
    Scand J Clin Lab Invest Suppl; 1986 Nov 28; 184():3-10. PubMed ID: 2438746
    [Abstract] [Full Text] [Related]

  • 8. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT, Skjeldal OH, Stokke O, Poulos A, Demaugre F, Saudubray JM.
    Hum Genet; 1989 Jan 28; 81(2):175-81. PubMed ID: 2463966
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
    Watkins PA, Mihalik SJ.
    Biochem Biophys Res Commun; 1990 Mar 16; 167(2):580-6. PubMed ID: 1690986
    [Abstract] [Full Text] [Related]

  • 10. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
    Skjeldal OH, Stokke O, Norseth J, Lie SO.
    Scand J Clin Lab Invest; 1986 May 16; 46(3):283-7. PubMed ID: 2424078
    [Abstract] [Full Text] [Related]

  • 11. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S.
    Riv Patol Nerv Ment; 1976 Jun 16; 97(3):115-26. PubMed ID: 74082
    [Abstract] [Full Text] [Related]

  • 12. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
    Skjeldal OH, Stokke O.
    Scand J Clin Lab Invest; 1988 Feb 16; 48(1):97-102. PubMed ID: 2464193
    [Abstract] [Full Text] [Related]

  • 13. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver.
    Scotto JM, Hadchouel M, Odievre M, Laudat MH, Saudubray JM, Dulac O, Beucler I, Beaune P.
    J Inherit Metab Dis; 1982 Feb 16; 5(2):83-90. PubMed ID: 6188882
    [Abstract] [Full Text] [Related]

  • 14. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B, Kainz-Korschinsky M, Sundt-Heller R, Bernheimer H.
    J Clin Chem Clin Biochem; 1989 May 16; 27(5):309-14. PubMed ID: 2474624
    [Abstract] [Full Text] [Related]

  • 15. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH, Stokke O, Refsum S, Norseth J, Petit H.
    J Neurol Sci; 1987 Jan 16; 77(1):87-96. PubMed ID: 2433405
    [Abstract] [Full Text] [Related]

  • 16. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
    Yao JK, Dyck PJ.
    Lipids; 1987 Feb 16; 22(2):69-75. PubMed ID: 2436023
    [Abstract] [Full Text] [Related]

  • 17. Plasma exchange for Refsum's disease.
    Gibberd FB.
    Transfus Sci; 1993 Jan 16; 14(1):23-6. PubMed ID: 10150979
    [Abstract] [Full Text] [Related]

  • 18. [Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum's syndrome). Effect of diet therapy on retinal and cochlear changes].
    Refsum S.
    Neurol Neurochir Pol; 1984 Jan 16; 18(1):1-4. PubMed ID: 6203044
    [No Abstract] [Full Text] [Related]

  • 19. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease.
    Molzer B, Bernheimer H, Barolin GS, Höfinger E, Lenz H.
    Clin Chim Acta; 1979 Jan 15; 91(2):133-40. PubMed ID: 83207
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of Refsum's disease using [1-14C]phytanic acid as substrate.
    Poulos A.
    Clin Genet; 1981 Oct 15; 20(4):247-53. PubMed ID: 6174257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.